Kaempferol Inhibits Angiogenesis by Suppressing HIF-1α and VEGFR2 Activation via ERK/p38 MAPK and PI3K/Akt/mTOR Signaling Pathways in Endothelial Cells
Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activate...
Saved in:
Published in | Preventive nutrition and food science Vol. 22; no. 4; pp. 320 - 326 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Korea (South)
한국식품영양과학회
01.12.2017
The Korean Society of Food Science and Nutrition |
Subjects | |
Online Access | Get full text |
ISSN | 2287-1098 2287-8602 |
DOI | 10.3746/pnf.2017.22.4.320 |
Cover
Abstract | Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathways in endothelial cells. Endothelial cells were treated with various concentrations of kaempferol for 24 h. Cell viability was determined by the 3- (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay; vascular formation was analyzed by tube formation, wound healing, and mouse aortic ring assays. Activation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor receptor 2 (VEGFR2), ERK/p38 MAPK, and PI3K/Akt/mTOR was analyzed by Western blotting. Kaempferol significantly inhibited cell migration and tube formation in endothelial cells, and suppressed microvessel sprouting in the mouse aortic ring assay. Moreover, kaempferol suppressed the activation of HIF-1α, VEGFR2, and other markers of ERK/p38 MAPK and PI3K/Akt/mTOR signaling pathways in endothelial cells. These results suggest that kaempferol inhibits angiogenesis by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and PI3K/Akt/mTOR signaling in endothelial cells. |
---|---|
AbstractList | Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathways in endothelial cells. Endothelial cells were treated with various concentrations of kaempferol for 24 h. Cell viability was determined by the 3- (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay; vascular formation was analyzed by tube formation, wound healing, and mouse aortic ring assays. Activation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor receptor 2 (VEGFR2), ERK/p38 MAPK, and PI3K/Akt/mTOR was analyzed by Western blotting. Kaempferol significantly inhibited cell migration and tube formation in endothelial cells, and suppressed microvessel sprouting in the mouse aortic ring assay. Moreover, kaempferol suppressed the activation of HIF-1α, VEGFR2, and other markers of ERK/p38 MAPK and PI3K/Akt/mTOR signaling pathways in endothelial cells. These results suggest that kaempferol inhibits angiogenesis by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and PI3K/Akt/mTOR signaling in endothelial cells. KCI Citation Count: 0 Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathways in endothelial cells. Endothelial cells were treated with various concentrations of kaempferol for 24 h. Cell viability was determined by the 3- (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay; vascular formation was analyzed by tube formation, wound healing, and mouse aortic ring assays. Activation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor receptor 2 (VEGFR2), ERK/p38 MAPK, and PI3K/Akt/mTOR was analyzed by Western blotting. Kaempferol significantly inhibited cell migration and tube formation in endothelial cells, and suppressed microvessel sprouting in the mouse aortic ring assay. Moreover, kaempferol suppressed the activation of HIF-1α, VEGFR2, and other markers of ERK/p38 MAPK and PI3K/Akt/mTOR signaling pathways in endothelial cells. These results suggest that kaempferol inhibits angiogenesis by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and PI3K/Akt/mTOR signaling in endothelial cells. Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathways in endothelial cells. Endothelial cells were treated with various concentrations of kaempferol for 24 h. Cell viability was determined by the 3- (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay; vascular formation was analyzed by tube formation, wound healing, and mouse aortic ring assays. Activation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor receptor 2 (VEGFR2), ERK/p38 MAPK, and PI3K/Akt/mTOR was analyzed by Western blotting. Kaempferol significantly inhibited cell migration and tube formation in endothelial cells, and suppressed microvessel sprouting in the mouse aortic ring assay. Moreover, kaempferol suppressed the activation of HIF-1α, VEGFR2, and other markers of ERK/p38 MAPK and PI3K/Akt/mTOR signaling pathways in endothelial cells. These results suggest that kaempferol inhibits angiogenesis by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and PI3K/Akt/mTOR signaling in endothelial cells.Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present study, we evaluated whether kaempferol exerts antiangiogenic effects by targeting extracellular signal-regulated kinase (ERK)/p38 mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signaling pathways in endothelial cells. Endothelial cells were treated with various concentrations of kaempferol for 24 h. Cell viability was determined by the 3- (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay; vascular formation was analyzed by tube formation, wound healing, and mouse aortic ring assays. Activation of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor receptor 2 (VEGFR2), ERK/p38 MAPK, and PI3K/Akt/mTOR was analyzed by Western blotting. Kaempferol significantly inhibited cell migration and tube formation in endothelial cells, and suppressed microvessel sprouting in the mouse aortic ring assay. Moreover, kaempferol suppressed the activation of HIF-1α, VEGFR2, and other markers of ERK/p38 MAPK and PI3K/Akt/mTOR signaling pathways in endothelial cells. These results suggest that kaempferol inhibits angiogenesis by suppressing HIF-1α and VEGFR2 activation via ERK/p38 MAPK and PI3K/Akt/mTOR signaling in endothelial cells. |
Author | Gi Dae Kim |
Author_xml | – sequence: 1 givenname: Gi Dae surname: Kim fullname: Kim, Gi Dae |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29333385$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002303606$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kt9u0zAUxiM0xMbYA3CDfIM0LtL6TxI7N0hRabeqg1Zd4dZybSc1TZwQp0V9E15jL7Jnwv2zCbjAN8eSf9_36fic18GZra0OgrcI9giNkn5j8x6GiPYw7kU9guGL4AJjRkOWQHx2uiOYsvPgyrnvEEKEcBpj-io4xynxh8UXwa-J0FWT67YuwdiuzNJ0DmS2MHWhrXbGgeUO3G-aptXOGVuA2_EoRI8PQFgFvg1vRnMMMtmZrehMbcHWCDCcT_oNYeBzNpscsNmYTPrZuutXi-kc3JvCinJvNRPd6qfYOWAsGFpVdytdGlGCgS5L9yZ4mYvS6atTvQy-joaLwW14N70ZD7K7UBLIYEiQhAmDmjFFVCxSmYtlIqlKWMRooiEjkZIoUjFVhORM5xAqhZCOE0ygkoRcBh-OvrbN-VoaXgtzqEXN1y3P5osxxziiMYae_Xhkm82y0kpq27Wi5E1rKtHuDsq_X6xZeZ8tj2nMYJp4g-uTQVv_2GjX8co46dsVVtcbx1HK0pj56VKPvvsz6znkaXQeoEdAtrVzrc65NN1hCj7alBxBvt8T7veE7_fEd8EjTg5toH-UT-b_07w_fdPGs1oZ8Sz6Mv00hBSzhCBMfgNScsyM |
CitedBy_id | crossref_primary_10_1096_fba_2019_00071 crossref_primary_10_1186_s12935_022_02666_z crossref_primary_10_2147_DDDT_S274980 crossref_primary_10_3390_molecules29071570 crossref_primary_10_3892_mmr_2019_10747 crossref_primary_10_1080_10408398_2022_2121261 crossref_primary_10_1016_j_intimp_2019_02_014 crossref_primary_10_1016_j_intimp_2025_114387 crossref_primary_10_1155_2021_4652492 crossref_primary_10_1097_MS9_0000000000002392 crossref_primary_10_3390_cancers11101618 crossref_primary_10_1111_cas_14168 crossref_primary_10_3390_ijms222212455 crossref_primary_10_2147_DDDT_S284163 crossref_primary_10_3390_pharmaceutics14020256 crossref_primary_10_3390_ijms24108630 crossref_primary_10_1016_j_jnutbio_2021_108634 crossref_primary_10_1038_s41598_020_63232_z crossref_primary_10_1016_j_phymed_2023_154658 crossref_primary_10_1155_2022_5093486 crossref_primary_10_1016_j_phymed_2022_154413 crossref_primary_10_1002_med_21985 crossref_primary_10_1016_j_biopha_2021_111419 crossref_primary_10_1016_j_jss_2018_08_009 crossref_primary_10_1186_s13020_021_00473_8 crossref_primary_10_1155_2022_5497991 crossref_primary_10_1016_j_ijbiomac_2019_02_003 crossref_primary_10_1016_j_jtcme_2024_04_009 crossref_primary_10_1002_ptr_6577 crossref_primary_10_1016_j_jep_2020_112664 crossref_primary_10_4103_wjtcm_wjtcm_56_24 crossref_primary_10_1016_j_cellsig_2023_110843 crossref_primary_10_1097_MD_0000000000032132 crossref_primary_10_1080_10408398_2022_2155106 crossref_primary_10_1016_j_gene_2019_01_043 |
ContentType | Journal Article |
Copyright | Copyright © 2017 by The Korean Society of Food Science and Nutrition 2017 |
Copyright_xml | – notice: Copyright © 2017 by The Korean Society of Food Science and Nutrition 2017 |
DBID | DBRKI TDB AAYXX CITATION NPM 7X8 5PM ACYCR |
DOI | 10.3746/pnf.2017.22.4.320 |
DatabaseName | DBPIA - 디비피아 Nurimedia DBPIA Journals CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2287-8602 |
EndPage | 326 |
ExternalDocumentID | oai_kci_go_kr_ARTI_2247520 PMC5758096 29333385 10_3746_pnf_2017_22_4_320 NODE07286312 |
Genre | Journal Article |
GroupedDBID | 9ZL ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS DBRKI DIK GW5 HYE JDI KVFHK OK1 RPM TDB AAYXX CITATION .UV NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c3080-31c0680e88d3d5a9cfab6c7d684876e0834dc14d57d33f8ef00dd11e56230dc33 |
ISSN | 2287-1098 |
IngestDate | Wed Jan 22 07:38:00 EST 2025 Thu Aug 21 18:42:00 EDT 2025 Fri Jul 11 14:30:24 EDT 2025 Wed Feb 19 02:44:23 EST 2025 Thu Apr 24 22:59:49 EDT 2025 Tue Jul 01 03:44:00 EDT 2025 Thu Mar 13 19:37:06 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | kaempferol angiogenesis HUVECS |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3080-31c0680e88d3d5a9cfab6c7d684876e0834dc14d57d33f8ef00dd11e56230dc33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC5758096 |
PMID | 29333385 |
PQID | 1989587467 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_2247520 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5758096 proquest_miscellaneous_1989587467 pubmed_primary_29333385 crossref_citationtrail_10_3746_pnf_2017_22_4_320 crossref_primary_10_3746_pnf_2017_22_4_320 nurimedia_primary_NODE07286312 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20171201 |
PublicationDateYYYYMMDD | 2017-12-01 |
PublicationDate_xml | – month: 12 year: 2017 text: 20171201 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Preventive nutrition and food science |
PublicationTitleAlternate | Prev Nutr Food Sci |
PublicationYear | 2017 |
Publisher | 한국식품영양과학회 The Korean Society of Food Science and Nutrition |
Publisher_xml | – name: 한국식품영양과학회 – name: The Korean Society of Food Science and Nutrition |
References | 18463380 - N Engl J Med. 2008 May 8;358(19):2039-49 15602010 - Pharmacol Rev. 2004 Dec;56(4):549-80 10815805 - Oncogene. 2000 Apr 20;19(17 ):2138-46 22260680 - Biochem Soc Trans. 2012 Feb;40(1):139-46 14712224 - Oncogene. 2004 Jan 8;23(1):192-200 9109485 - Nature. 1997 Apr 17;386(6626):671-4 11772931 - FASEB J. 2002 Jan;16(1):2-14 17220336 - Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):98-101 28534212 - Cell Oncol (Dordr). 2017 Jun;40(3):199-208 17471564 - Int J Cancer. 2007 Nov 15;121(10):2225-32 12816951 - J Biol Chem. 2003 Sep 12;278(37):35501-7 18922108 - Expert Opin Investig Drugs. 2008 Nov;17(11):1717-34 12121824 - J Nutr Biochem. 2002 Jul;13(7):380-390 15488631 - Cancer Lett. 2004 Nov 25;215(2):129-40 12039858 - FASEB J. 2002 Jun;16(8):771-80 17583406 - Food Chem Toxicol. 2007 Oct;45(10):2005-13 16254106 - J Clin Pathol. 2005 Nov;58(11):1170-4 16169200 - J Nutr Biochem. 2006 Mar;17(3):165-76 10652234 - Biochem Biophys Res Commun. 2000 Feb 5;268(1):183-91 22144946 - Front Mol Neurosci. 2011 Dec 02;4:51 14603522 - J Cell Physiol. 2004 Feb;198(2):197-208 17344514 - Am J Clin Nutr. 2007 Mar;85(3):895-909 19005980 - Nutr Cancer. 2008;60(6):800-9 21992728 - Future Oncol. 2011 Oct;7(10):1149-67 22193302 - Nat Protoc. 2011 Dec 22;7(1):89-104 16289744 - Toxicol In Vitro. 2006 Mar;20(2):187-210 18590808 - Toxicol Lett. 2008 Aug 28;180(3):166-73 8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13 15928673 - Nat Rev Cancer. 2005 Jun;5(6):423-35 16336951 - Cardiovasc Res. 2006 Feb 1;69(2):512-9 |
References_xml | – reference: 11772931 - FASEB J. 2002 Jan;16(1):2-14 – reference: 18590808 - Toxicol Lett. 2008 Aug 28;180(3):166-73 – reference: 12816951 - J Biol Chem. 2003 Sep 12;278(37):35501-7 – reference: 15602010 - Pharmacol Rev. 2004 Dec;56(4):549-80 – reference: 16254106 - J Clin Pathol. 2005 Nov;58(11):1170-4 – reference: 12121824 - J Nutr Biochem. 2002 Jul;13(7):380-390 – reference: 22260680 - Biochem Soc Trans. 2012 Feb;40(1):139-46 – reference: 12039858 - FASEB J. 2002 Jun;16(8):771-80 – reference: 16336951 - Cardiovasc Res. 2006 Feb 1;69(2):512-9 – reference: 19005980 - Nutr Cancer. 2008;60(6):800-9 – reference: 17344514 - Am J Clin Nutr. 2007 Mar;85(3):895-909 – reference: 18922108 - Expert Opin Investig Drugs. 2008 Nov;17(11):1717-34 – reference: 16169200 - J Nutr Biochem. 2006 Mar;17(3):165-76 – reference: 15928673 - Nat Rev Cancer. 2005 Jun;5(6):423-35 – reference: 14603522 - J Cell Physiol. 2004 Feb;198(2):197-208 – reference: 17220336 - Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):98-101 – reference: 22144946 - Front Mol Neurosci. 2011 Dec 02;4:51 – reference: 21992728 - Future Oncol. 2011 Oct;7(10):1149-67 – reference: 18463380 - N Engl J Med. 2008 May 8;358(19):2039-49 – reference: 17471564 - Int J Cancer. 2007 Nov 15;121(10):2225-32 – reference: 17583406 - Food Chem Toxicol. 2007 Oct;45(10):2005-13 – reference: 28534212 - Cell Oncol (Dordr). 2017 Jun;40(3):199-208 – reference: 10815805 - Oncogene. 2000 Apr 20;19(17 ):2138-46 – reference: 22193302 - Nat Protoc. 2011 Dec 22;7(1):89-104 – reference: 9109485 - Nature. 1997 Apr 17;386(6626):671-4 – reference: 16289744 - Toxicol In Vitro. 2006 Mar;20(2):187-210 – reference: 8756616 - Mol Cell Biol. 1996 Sep;16(9):4604-13 – reference: 15488631 - Cancer Lett. 2004 Nov 25;215(2):129-40 – reference: 14712224 - Oncogene. 2004 Jan 8;23(1):192-200 – reference: 10652234 - Biochem Biophys Res Commun. 2000 Feb 5;268(1):183-91 |
SSID | ssj0001129527 |
Score | 2.0413055 |
Snippet | Kaempferol has been shown to inhibit vascular formation in endothelial cells. However, the underlying mechanisms are not fully understood. In the present... |
SourceID | nrf pubmedcentral proquest pubmed crossref nurimedia |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 320 |
SubjectTerms | 식품과학 |
Title | Kaempferol Inhibits Angiogenesis by Suppressing HIF-1α and VEGFR2 Activation via ERK/p38 MAPK and PI3K/Akt/mTOR Signaling Pathways in Endothelial Cells |
URI | https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE07286312 https://www.ncbi.nlm.nih.gov/pubmed/29333385 https://www.proquest.com/docview/1989587467 https://pubmed.ncbi.nlm.nih.gov/PMC5758096 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002303606 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Preventive Nutrition and Food Science, 2017, 22(4), , pp.320-326 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbYuIAbBOKvAyaD2A1R28RJnPSyjHQr-9Xo0O6sJHa6qJ07devQeBJegxfhmTjHadKUTWjQi7RyHTvS9_nkHPv8EPLe8zthqFLV5BK3bhzZaSaKJU2ecZ4k0Ob7GI28t8-3j73PJ_7JomariS65TFrp91vjSv4HVWgDXDFK9h-QrQaFBvgN-MIVEIbrnTDeidXZeabQ1byvT_MEDwG6ephPhijB8gvULbFsp_F11UNru99rOhub0cZHxxwafI22ekfM6qZljTPrKo-t6GgHS_K6obXXPdwpwgn6LrZ1RyCye2eDgyPrSz5EFR4GPQQd8lt8bfxqIy0xomuM2_Cbajy-qOu-ZbaoK2XpsgaAGT3DzMrzV_HCJ8AQdSsHXqr61gS87hZuHkaCMTDHQM4XZaZLcctYjVZeTXa6Jiruhkx3A5PM-FybhKtBi7GW15r3Xc6fvX8gese7u2IQnQxWyH0WBObgvty_MbtuoN4UdXyrZyuOunGW9o05lpSVFT2F6wM9w7oLsHhvs0n-dK2t6SqDx-TR3Mig3YIxT8g9pZ-SHwu20JIttM4WmlzTGluoYcuvnxQgogVT6IIpFJhCgSlt4AlFnphuyJM2sKSNHKEVR2jJEZprWuMINRx5Ro570WBzuzmvy9FMXTAw4LWdYsUWFYbSlX7cSbM44WkgeQjWL1eg1HsydTzpB9J1s1Blti2l4yhUtW2Zuu5zsqonWr0kFKwTxjPfVjHcFGd-x0sCHksedxjmEEkbxC4BEOk8aT3WThkLMF4RMwGYCcRMMCY8AZg1yIfqlvMiY8vfOr8DVMUozQXmWcfv4USMpgKsyT708gIfO61XoFdD7h98iuyAhdx1WIO8LZkgQDrjkVus1WR2IdAj0Q-xpE-DvCiYUY0AijZ8Qr9BgiXOVB3wiZb_0fmpyQAPNlZod_jaHeZ9RR4uluZrsno5nak3oEdfJutmafwGl1_GNQ |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kaempferol+Inhibits+Angiogenesis+by+Suppressing+HIF-1%CE%B1+and+VEGFR2+Activation+via+ERK%2Fp38+MAPK+and+PI3K%2FAkt%2FmTOR+Signaling+Pathways+in+Endothelial+Cells&rft.jtitle=Preventive+nutrition+and+food+science&rft.au=Kim%2C+Gi+Dae&rft.date=2017-12-01&rft.issn=2287-1098&rft.volume=22&rft.issue=4&rft.spage=320&rft_id=info:doi/10.3746%2Fpnf.2017.22.4.320&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-1098&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-1098&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-1098&client=summon |